# Bruker (BRKR) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/BRKR
## Company Profile
- Ticker: BRKR
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 58.5 USD
- Market cap: 8724050511.44 USD
- Last updated: 2026-09-04
## Business Overview
### Scientific Instrumentation
Bruker develops high-performance scientific instruments and analytical solutions used to study life and materials at molecular, cellular and microscopic scales.
### Life-Science Research
Its systems support molecular and cell biology, proteomics, multiomics, spatial and single-cell biology, structural biology and preclinical imaging. These tools serve academic, government and biopharmaceutical research laboratories.
### Clinical Diagnostics
Bruker provides specialty diagnostic technologies for clinical microbiology, molecular diagnostics and phenomics research, connecting its instrument base with healthcare applications.
### Materials and Nanoanalysis
The company also supplies microscopy, spectroscopy and nanoanalysis systems for industrial, energy, clean-technology and advanced-materials research.
### Semiconductor Metrology
Bruker's semiconductor tools perform next-generation metrology and process analysis, giving the company exposure to advanced chip manufacturing and infrastructure supporting artificial intelligence.
## Why The Stock Is Moving

As of Sep 4, 2026, BRKR closed down 1.53% at $58.50. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-11 11:00 EST — [Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories](https://biopharmsignal.com/news/BRKR/bruker-announces-strategic-collaboration-with-atinary-technologies-to-advance-se-b1a31281) — Source: Bruker
- 2026-08-10 11:00 EST — [Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development](https://biopharmsignal.com/news/BRKR/bruker-announces-majority-investment-in-mimetas-to-advance-human-physiology-rele-3f432fc9) — Source: Bruker
- 2026-08-04 11:00 EST — [Bruker Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/BRKR/bruker-reports-second-quarter-2026-financial-results-4f25580a) — Source: Bruker
- 2026-07-24 20:01 EST — [Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast](https://biopharmsignal.com/news/BRKR/bruker-announces-date-and-time-of-second-quarter-2026-earnings-release-and-webca-29470a21) — Source: Bruker
- 2026-07-15 11:00 EST — [Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood](https://biopharmsignal.com/news/BRKR/bruker-expands-infection-detection-portfolio-with-acquisition-of-metagenomic-mng-36c3ebd1) — Source: Bruker